BioCatalyst

URGN — UroGen Pharma Ltd. catalysts

1 verified catalyst event(s) for UroGen Pharma Ltd. (ticker URGN). Each is linked to its official source. Verified as of 2026-11-02.

Next verified catalyst

2027-03-01 — A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelia · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03 (month)
in 4mo
ESTIMATED
 READOUT
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract
Phase 3 · Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
 URGN UroGen Pharma Ltd. UGN-104 ClinicalTrials.gov ↗
✓ Source-checked 2026-11-02
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.